
The DOJ has put benefits fraud qui tam cases on an accelerated enforcement track, and companies may need to move just as quickly.
A new Civil Division memorandum directs DOJ attorneys and Assistant U.S. Attorneys handling False Claims Act matters to dramatically compress the timeline for investigating and making intervention decisions in qui tam actions involving federally funded, state-administered benefits programs.
That shift could have significant implications for companies participating in programs such as Medicaid, SNAP, Community Development Block Grants, TANF, and similar benefits programs. Allegations that once unfolded over a longer investigative timeline may now require faster assessment, coordination, and decisions.
In a new alert, Ropes & Gray attorneys Amy Kossak, Diana Cieslak, and Jaime Feeney examine the key provisions of the memo and what companies should understand about this evolving enforcement environment.
#DOJ enforcement #benefits fraud #False Claims Act #Medicaid compliance #snap regulations
A new Civil Division memorandum directs DOJ attorneys and Assistant U.S. Attorneys handling False Claims Act matters to dramatically compress the timeline for investigating and making intervention decisions in qui tam actions involving federally funded, state-administered benefits programs.
That shift could have significant implications for companies participating in programs such as Medicaid, SNAP, Community Development Block Grants, TANF, and similar benefits programs. Allegations that once unfolded over a longer investigative timeline may now require faster assessment, coordination, and decisions.
In a new alert, Ropes & Gray attorneys Amy Kossak, Diana Cieslak, and Jaime Feeney examine the key provisions of the memo and what companies should understand about this evolving enforcement environment.
#DOJ enforcement #benefits fraud #False Claims Act #Medicaid compliance #snap regulations
Shared byJordan Khan - 4 days ago
Log in to comment
Loading ..
Related Articles
American Industrial Partners Completes $1.5B Molycop Sale to Tega Industries
Celebrating 25 Years of Ropes & Gray's New York Office and Innovative Legal Solutions
Impact of DOL Safe Harbor on Alternative Investments in 401(k) Plans Webinar
Rallybio to Acquire Avenzo Therapeutics: Advancing Oncology Therapies
Strategic Financing Collaboration Supports Development of Atopic Dermatitis Treatment
Europe's Data Center Market Booms with €1.2B Financing for AtlasEdge
2
0/100